Nordic Health Group

What Nordic Health Group does

Nordic Health Group is a privately held, Copenhagen-based healthcare services company founded in 2016 by Thomas Lawaetz that operates 60+ specialised clinics across five Northern European countries (Denmark, Sweden, Norway, the Netherlands and the United Kingdom) under regional brands Dansk Venecenter, Åderbråcksklinikerna, Åreknuteklinikkene, Vaatzorgkliniek and UK Vein Care. The company treats one medical condition exclusively — varicose and spider veins — using minimally invasive procedures (Endovenous Laser Ablation, foam sclerotherapy and phlebectomy) performed by 45+ specialised vascular surgeons supported by structured duplex-ultrasound diagnostics and the proprietary Nordic Treatment Protocol, with quality benchmarked at a 97.4% patient satisfaction rate across 55,000+ cumulative treatments.

The business model is direct-to-patient healthcare services delivered through wholly-owned clinics, combining self-pay patients (notably in the Netherlands and UK) with publicly referred and insured patients via agreements with major insurance companies and regional health authorities (notably in Denmark, Sweden and Norway). Go-to-market is sales-led and clinic-led: the company grows by establishing physical clinics in underserved localities, layered with data-driven digital marketing across blog, LinkedIn, Instagram and Facebook channels. Revenue is not publicly disclosed and the company has raised no external institutional capital; expansion is funded internally, with five countries entered via greenfield build-outs and acquisitions of local clinic chains rather than large M&A.

Operationally, the platform is supported by NHG Academy, an in-house training and development function that runs quarterly joint conferences and formal protocol training to maintain clinical consistency across markets. Headcount stands at 130+ people across five countries, with leadership comprising founder/CEO Thomas Lawaetz, Chief People & Operations Officer Martin Haakansson, COO Magnus Lysemose, Group Director for Clinical and Operational Excellence Henning Johnsen, and Finance Manager Leo Noer. The most recent disclosed operational milestone is the April 2025 opening of the group's 50th clinic in Luleå, Sweden.

Name

Nordic Health Group

Legal name

Nordic Health Group

Website

https://nordichealthgroup.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

101–250 employees

Short description

Nordic Health Group operates 60+ specialized clinics across Denmark, Sweden, Norway, the Netherlands and the UK, delivering minimally invasive varicose and spider vein treatments to adult patients under a standardised Nordic Treatment Protocol, served by 45+ specialised vascular surgeons.

Ownership category

akta.pro rank

Product category

Vascular Healthcare Services

NAICS

Offices of Physicians (except Mental Health Specialists) (621111), Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Independent Primary Care Practices (HLAFAGAA)

Keywords

• Varicose vein treatment
• Minimally invasive procedures
• Specialised vascular surgery
• Vein care clinics
• Spider vein therapy

Headquarters

HQ city

Copenhagen

HQ country

Denmark

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Healthcare Services - Varicose Vein Treatment: Revenue generated from performing minimally invasive varicose vein treatments at company-owned clinics. Services include EVLA, foam sclerotherapy, and phlebectomy procedures. Revenue comes from both privately funded patients and publicly funded/referred patients through insurance agreements with major insurance companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Nordic Health Group operates a network of 60+ specialised clinics across Denmark, Sweden, Norway, the Netherlands, and the United Kingdom that deliver minimally invasive treatment of varicose veins and spider veins. The company performs Endovenous Laser Ablation (EVLA), foam sclerotherapy, and phlebectomy under the standardised Nordic Treatment Protocol, serving both privately funded patients and those referred through public healthcare and insurance agreements.

Product overview

Nordic Health Group is a healthcare services company operating 60+ specialized clinics across five countries under five regional brands: Dansk Venecenter (Denmark, 7 clinics), Åderbråcksklinikerna (Sweden, 18 clinics), Åreknuteklinikkene (Norway), UK Vein Care (UK, 12 clinics), and Vaatzorgkliniek (Netherlands, 9 clinics). The company focuses exclusively on minimally invasive varicose vein and spider vein treatment using standardized clinical protocols across all locations. Core treatment procedures include Endovenous Laser Ablation (EVLA), foam sclerotherapy, and phlebectomy. Supporting the clinical operations is NHG Academy, an internal training platform that provides formalized education in the Nordic Treatment Protocol, quarterly joint conferences, and ongoing professional development for clinical staff.

Differentiator

Problem solved

Functional benefit

Products and services

• Dansk Venecenter
• Åderbråcksklinikerna
• Åreknuteklinikkene
• UK Vein Care
• Vaatzorgkliniek
• Endovenous Laser Ablation (EVLA) Minimally invasive laser treatment for varicose veins using controlled laser energy to close off malfunctioning veins. One of the modern treatment methods used across all Nordic Health Group clinics.
• Foam Sclerotherapy Minimally invasive injectable treatment for varicose veins in which a foam sclerosant is injected into the affected vein to close it. Used in combination with other methods based on individual patient anatomy across Nordic Health Group clinics.
• Phlebectomy Minimally invasive surgical procedure for removing varicose veins through small punctures in the skin. Used as part of the combined treatment approach based on individual patient needs across Nordic Health Group clinics.

Quantifiable outcome

• 97.4% patient satisfaction rate across 55,000+ treatments
• +2 more outcomes

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators7 records

Recent moves8 records

Expansion highlights4 records

Direct peers

• The Private Clinic: UK network of clinics offering vein treatments alongside cosmetic and aesthetic procedures. Overlaps with NHG in minimally invasive vein care and competes for the same private patient segment in the UK.
• Venenklinik Dr. Dorow: Specialist vein treatment clinic in Germany focused on minimally invasive procedures (EVLA, sclerotherapy). Direct competitor that NHG would likely encounter as an expansion target or competitor in the German market.
• Vein Clinics of America: Once the largest US specialist vein treatment chain (now under IntegraMed/Shaun Stack ownership). The historical US analogue of NHG's roll-up strategy: standardized protocols, multi-clinic network, single-specialty focus. Useful comparable for unit economics and scaling lessons.
• Veincentre: One of the UK's largest specialist vein treatment clinic networks using radiofrequency ablation, EVLA, and foam sclerotherapy. Competes head-to-head with UK Vein Care for private-pay vein patients and demonstrates the chain-clinic model NHG emulates in the UK.
• Whiteley Clinics: UK-based chain specializing in minimally invasive varicose vein treatment under the Whiteley Protocol, founded by Prof. Mark Whiteley. Direct competitor to UK Vein Care in the UK private vein-treatment segment and a strong specialist alternative to NHG's UK operations.

Broad incumbents

• Capio (part of Ramsay Santé): Major Northern European private healthcare provider (Sweden, Norway, Denmark, France, Germany) operating specialist clinics and hospitals including vascular services. Could be a strategic acquirer of NHG or an incumbent competitor in the Nordic markets where NHG leads today.
• Spire Healthcare: UK-listed private hospital group operating 38+ hospitals that perform vascular and vein surgery alongside broader elective care. Provides ambulatory competition for UK Vein Care patients and could be an acquisition or strategic-partner counterparty for NHG's UK business.
• Artemed Kliniken: Network of German specialist hospitals/clinics, several of which run vascular and vein surgery programs. Representative of the broad-incumbent hospital-based competition NHG would face in continental Europe.
• Ramsay Health Care UK (Ramsay Sime Darby): Large private hospital operator in the UK (and globally) that performs vein surgery as part of a broader elective-surgery portfolio. Represents the broad-incumbent threat: hospital networks that can add vein services without changing their core model.

Emerging players

• sk:n / Acıbadem Beauty & Vein: UK skin and aesthetic clinic chain that has offered vein treatments in select locations. Emerging player with partial overlap, illustrating the overlap between aesthetic/cosmetic chains and specialist vein clinics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Nordic-Health-Group-100024848896872
• LinkedInlinkedin.com/company/nordic-health-group
• Instagraminstagram.com/aderbracksklinikerna

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nordic Health Group